©2025 Stanford Medicine
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
Not Recruiting
Trial ID: NCT06208878
Purpose
This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies
Official Title
A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies
Stanford Investigator(s)
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
Eligibility
Inclusion Criteria:
* Able to understand and comply with protocol-required study procedures and voluntarily sign and date a written informed consent document.
* Must have received CRISPR CAR T cellular therapy.
Exclusion Criteria:
* There are no specific exclusion criteria.
Intervention(s):
other: Non Interventional
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Vivian Leung